April 17, 2009 – GE Healthcare is introducing three service agreements for owners of GE monitoring and diagnostic cardiology products and solutions, including telemetry, patient and Holter monitors, and cardiac stress, cardiology management and electrocardiograph systems.

April 16, 2009 - An estimated 1,000 lives could be saved each year if heart attack patients received faster emergency care during and immediately after a heart attack. Recognizing that each minute lost could mean the difference between saving a life - or losing it - mobile intensive care unit (MICU) first responders from St.

April 16, 2009 -Twelve-month data from the ZEST trial presented at ACC 2009 showed the Endeavor Drug-Eluting Stent (DES) from Medtronic Inc. was associated with a statistically significant 29 percent reduction in a composite primary endpoint of death, myocardial infarction (MI) and in ischemia-driven target vessel revascularization (TVR), when compared to the Taxus Liberte DES.

April 15, 2009 - The results of the Detection of Ischemia in Asymptomatic Diabetes (DIAD) study, released in today’s Journal of the American Medical Association (JAMA), found that myocardial perfusion imaging (MPI) screening for coronary artery disease (CAD) in asymptomatic patients with type 2 diabetes did not result in a significant reduction in the rate of heart attacks and death compared to

April 15, 2009 - Scranton Gillette Communications, located in Arlington Heights, IL, has agreed to acquire the assets of Imaging Technology News and Diagnostic & Invasive Cardiology from Reilly Communications Group, located in Schaumburg, IL. Imaging Technology News provides technology solutions for medical imaging and radiation oncology professionals with a circulation of 35,000.

April 15, 2009 - The American College of Cardiology (ACC) and the American Heart Association (AHA), in collaboration with the International Society for Heart and Lung Transplantation, have joined efforts to produce updated heart failure guidelines that focus on key research findings and clinical advances.

April 14, 2009 - Biotronik Inc. announced yesterday the first U.S. implant of the next-generation Lumax 540 Series defibrillator for treating patients with heart failure. The Lumax 540 Series was recently approved by the FDA.